MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Meridian Bioscience ROE 2011-2026 | VIVO
ROE Jährlich Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.54 | 21.75 | 18.65 | 12.77 | 13.6 | 12.71 | 19.36 | 21.43 | 21.58 | 24.53 | 23.38 | 19.37 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 24.53 | 11.54 | 18.39 |
ROE Vierteljährlich Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.59 | 19.79 | 15.74 | 19.36 | 19.31 | 20.84 | 23.47 | 29.71 | 31.69 | 23.52 | 23.05 | 15.76 | 7.59 | 10.69 | 11.64 | 12.89 | 15.99 | 15.1 | 15.38 | 11.7 | 10.81 | 10.95 | 10.87 | 15.99 | 16.12 | 17.6 | 19.41 | 19.64 | 21.23 | 20.87 | 20.84 | 20.84 | 20.39 | 20.19 | 21.01 | 22.08 | 23.78 | 25.19 | 25.3 | 24.76 | 24.09 | 22.74 | 21.58 | 20.49 | 19.3 | 4.84 | 4.93 | 4.75 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 31.69 | 4.75 | 17.93 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
22.45 | $ 118.41 | -1.12 % | $ 36 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 19.13 | -6.98 % | $ 206 M |  China |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 20.4 | 16.11 % | $ 1.09 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.44 | 1.24 % | $ 1.92 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 24.65 | 0.12 % | $ 685 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 182.43 | 0.98 % | $ 9.04 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 194.63 | -1.75 % | $ 139 B | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 2.2 | - | $ 9.73 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 129.72 | -1.92 % | $ 20.6 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 16.11 | -0.34 % | $ 487 M | USA |
 |
Guardant Health
GH
|
419.18 | $ 85.08 | 0.26 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B |  Niderland |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.57 | -1.32 % | $ 1.1 B | USA |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.88 | -1.7 % | $ 93.5 K | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.12 | 0.47 % | $ 4.87 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 527.68 | 1.76 % | $ 15.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 116.64 | 0.12 % | $ 9.62 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 268.68 | 0.67 % | $ 22.4 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 29.16 | 0.31 % | $ 20 B | Niderland |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Celcuity
CELC
|
-176.06 | $ 123.38 | -0.08 % | $ 5.77 B | USA |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 6.79 | -1.59 % | $ 283 M | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 5.12 | -1.35 % | $ 474 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 84.11 | 0.2 % | $ 5.68 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | $ 52.65 | 0.14 % | $ 2.68 B | USA |
 |
Neuronetics
STIM
|
-174.27 | $ 1.37 | -1.44 % | $ 90.4 M | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.36 | -0.64 % | $ 2.03 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 193.25 | 1.0 % | $ 21.5 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-310.93 | $ 5.14 | - | $ 4.05 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 17.73 | -0.62 % | $ 397 M | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 524.62 | -1.3 % | $ 198 B | USA |